drugset / Trial / NCT04483427
Multimodal Postoperative Analgesia Following OSA Surgery
NaSingle-groupOpen-labelTreatment
Summary
Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser) for postoperative analgesia following multilevel OSA surgeries
Timeline
- Start
- 2020-09-20
- Primary completion
- 2022-07
- Completion
- 2022-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketorolac | Other / unclassified | — | Intravenous |
| Subject | Nalbuphine | Small molecule | — | Intravenous |